Skip to main content
Premium Trial:

Request an Annual Quote

Lion Sells Its Bioinformatics Business to BioWisdom for $5M

NEW YORK, April 4 (GenomeWeb News) - BioWisdom Limited has acquired Lion Bioscience's bioinformatics business for approximately 4 million ($4.9 million), BioWisdom said today.


Under the terms of the agreement, BioWisdom, based in Cambridge, UK, will purchase the shares of Heidelberg, Germany-based Lion Bioscience and its subsidiary Lion Bioscience Asset Vehicle.


Lion markets the SRS software suit for data integration, for which it has approximately 300 commercial and academic customers. BioWisdom creates "intelligence networks" used to support decision making in all areas of drug discovery and development, and will integrate the SRS platform into its current products.


BioWisdom said that the SRS product development will remain in its Cambridge facilities, while Lion's US-based sales and support staff will remain in Boston.


Lion first announced the planned sale of its bioinformatics business in April 2005.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.